We use cookies to give you the best possible experience on our website.

The GM AHSN Innovation Funds have been established to support the introduction and adoption of needs-led, evidence-based innovations into our healthcare system within the GM AHSN footprint.  This will improve the health of our citizens and also promote economic development and wealth creation through the growth of local businesses and jobs.

The Ignite Fund is designed to support early stage development of innovative solutions to identify unmet need within the GM AHSN area. The theme for Ignite Fund applications is Prevention, Screening and Diagnostic Technology for products/services to improve health and well-being. The priority focus areas are mental health and cancer but applications in other areas will be considered.

The ignite fund is particularly aimed at collaborations led by HEI members with partners however applications from SMEs and NHS/Social Care are also welcome. Where an SME is part of the collaboration priority will be given to Greater Manchester based SMEs including inward investment companies who have a base in the GM area.

All applications must include involvement from an NHS or Social Care organisation from within GM AHSN’s footprint.

Applicants must apply using the Innovation Nexus portal and SMEs are advised to complete an Innovation Nexus business enquiry (via the same link) prior to applying to the Innovation funds. Other types of applicant are not required to take this step. Applications for the Ignite Fund close at 9am on 13th December 2016

The Ignite has up to a total of £80,000 available this year. Applicants may apply for funding up to a maximum value of £30,000 (inc. VAT).  Projects funded will typically last 6-12 months and will be monitored against agreed milestones and outputs. Applications for matched funding are particularly welcome, i.e. when part funding has been secured from another source but is subject to match funding from an alternative.

For more information about the Ignite Fund please read our application guidance.